Novo Nordisk readies once-a-week insulin shot for Indian market

Novo Nordisk is set to introduce Awiqli, an innovative once-weekly insulin, in India shortly. This remarkable treatment drastically cuts down the number of insulin injections from 365 annually to only 52. Awiqli could redefine the approach to diabetes management, offering promising cost savings compared to existing therapies.

Raccontata daeconomictimes.indiatimes.comthehindubusinessline.comhindustantimes.comnewsbytesapp.comthehindu.com